Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

Journal

  • Immunity

    Immunity 50 (6), 1498-1512.e5, 2019-06

    Elsevier BV

Citations (12)*help

See more

Report a problem

Back to top